DK0817858T3 - Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi - Google Patents

Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi

Info

Publication number
DK0817858T3
DK0817858T3 DK96907398T DK96907398T DK0817858T3 DK 0817858 T3 DK0817858 T3 DK 0817858T3 DK 96907398 T DK96907398 T DK 96907398T DK 96907398 T DK96907398 T DK 96907398T DK 0817858 T3 DK0817858 T3 DK 0817858T3
Authority
DK
Denmark
Prior art keywords
vectors
relates
present
antimicrobial peptides
gene therapy
Prior art date
Application number
DK96907398T
Other languages
Danish (da)
English (en)
Inventor
Walter H Guenzburg
David Winder
Robert Michael Saller
Original Assignee
Gsf Forschungszentrum Umwelt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gsf Forschungszentrum Umwelt filed Critical Gsf Forschungszentrum Umwelt
Application granted granted Critical
Publication of DK0817858T3 publication Critical patent/DK0817858T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43572—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from bees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Insects & Arthropods (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96907398T 1995-03-09 1996-03-08 Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi DK0817858T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK24395 1995-03-09
PCT/EP1996/001001 WO1996028563A1 (en) 1995-03-09 1996-03-08 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy

Publications (1)

Publication Number Publication Date
DK0817858T3 true DK0817858T3 (da) 2003-08-11

Family

ID=8091353

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96907398T DK0817858T3 (da) 1995-03-09 1996-03-08 Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi

Country Status (10)

Country Link
US (1) US7022319B1 (pt)
EP (1) EP0817858B1 (pt)
JP (1) JP3908274B2 (pt)
AT (1) ATE238427T1 (pt)
AU (1) AU5103996A (pt)
DE (1) DE69627644T2 (pt)
DK (1) DK0817858T3 (pt)
ES (1) ES2198479T3 (pt)
PT (1) PT817858E (pt)
WO (1) WO1996028563A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU688590B2 (en) * 1994-09-02 1998-03-12 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
GB9621680D0 (en) * 1996-10-17 1996-12-11 Oxford Biomedica Ltd Lentiviral vectors
US6924123B2 (en) 1996-10-29 2005-08-02 Oxford Biomedica (Uk) Limited Lentiviral LTR-deleted vector
GB9720465D0 (en) * 1997-09-25 1997-11-26 Oxford Biomedica Ltd Dual-virus vectors
AU747438B2 (en) 1997-09-24 2002-05-16 Regents Of The University Of California, The Non-primate lentiviral vectors and packaging systems
GB2344592B (en) * 1997-09-25 2002-09-11 Oxford Biomedica Ltd Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
EP1045922B1 (en) 1998-01-06 2004-09-29 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Reconstituting retroviral vector (recon vector) for targeted gene expression
GB9817693D0 (en) * 1998-08-14 1998-10-07 Bridgehead Technologies Limite Virally-mediated targeting of drugs and genetic material
DE19910650A1 (de) * 1999-03-10 2000-09-21 Gsf Forschungszentrum Umwelt Auf HERV-LTR-Sequenzen basierende retrovirale Expressionsvektoren
GB9906615D0 (en) * 1999-03-22 1999-05-19 Oxford Biomedica Ltd Vector
US8124749B2 (en) * 2007-06-12 2012-02-28 Case Western Reserve University Targeted cell death
EP2454276A4 (en) * 2008-07-17 2013-07-10 Inter K Pty Ltd THERAPEUTIC AGENTS

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR970006154B1 (ko) * 1987-07-06 1997-04-24 루이지아나 스테이트 유니버시티 아그리컬춰럴 앤드 메카니칼 컬리지 용해성 펩티드에 의한 진핵 병원체와 신생물의 억제 및 섬유아세포와 임파구의 자극
US4822608A (en) 1987-09-14 1989-04-18 Vespa Laboratories, Inc. Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom or proteinaceous or polypeptide components thereof
ATE142268T1 (de) 1988-05-17 1996-09-15 Sloan Kettering Inst Cancer Retroviraler vektor
US5658775A (en) * 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
US5124263A (en) * 1989-01-12 1992-06-23 Wisconsin Alumni Research Foundation Recombination resistant retroviral helper cell and products produced thereby
GB8919607D0 (en) 1989-08-30 1989-10-11 Wellcome Found Novel entities for cancer therapy
ATE110278T1 (de) * 1989-12-07 1994-09-15 Gsf Forschungszentrum Umwelt Verfahren und zubereitung für die behandlung von hiv-infizierten säugetieren.
US6027722A (en) * 1990-10-25 2000-02-22 Nature Technology Corporation Vectors for gene transfer
NZ244306A (en) * 1991-09-30 1995-07-26 Boehringer Ingelheim Int Composition for introducing nucleic acid complexes into eucaryotic cells, complex containing nucleic acid and endosomolytic agent, peptide with endosomolytic domain and nucleic acid binding domain and preparation
CA2121127A1 (en) * 1991-10-25 1993-04-29 Robert E. Sobol Lymphokine gene therapy of cancer
WO1995006415A1 (en) 1993-08-30 1995-03-09 Baylor College Of Medicine Senescent cell-derived inhibitors of dna synthesis
US5302706A (en) 1991-12-16 1994-04-12 Baylor College Of Medicine Senescent cell derived inhibitors of DNA synthesis
WO1994029437A1 (en) 1993-06-07 1994-12-22 University Of Medicine & Dentistry Of New Jersey Highly-efficient, self-inactivating, recombination-free, u3-free retroviral vectors
AU7177494A (en) 1993-06-25 1995-01-17 Board Of Regents, The University Of Texas System Pore-forming and superantigen encoding toxin cassettes for gene therapy
WO1995001095A1 (en) * 1993-06-30 1995-01-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Transformed eukaryotic cells, and transposon-based transformation vectors
WO1995013375A1 (en) 1993-11-10 1995-05-18 The Johns Hopkins University Tumor suppressor waf1
AU688590B2 (en) * 1994-09-02 1998-03-12 Gsf - Forschungszentrum Fur Umwelt Und Gesundheit Gmbh Non self-inactivating, expression targeted retroviral vectors
ATE212061T1 (de) 1995-03-09 2002-02-15 Austrian Nordic Biotherapeutic Rekombinante dna-vektoren für die gentherapie
GB9510272D0 (en) 1995-05-22 1995-07-19 Isis Innovation Retroviral vectors
CN1187095C (zh) 1995-06-27 2005-02-02 巴法里安诺迪克有限公司 可生产病毒颗粒的被囊化细胞
EP0848757B1 (en) 1995-09-06 2002-03-06 Austrian Nordic Biotherapeutics AG The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
US5863904A (en) 1995-09-26 1999-01-26 The University Of Michigan Methods for treating cancers and restenosis with P21
EP1025208A2 (en) 1997-10-20 2000-08-09 Universita' Degli Studi Di Padova A packaging cell line producing siv-pseudotyped mlv
EP1045922B1 (en) 1998-01-06 2004-09-29 Institut für Virologie Teilrechtsfähiges Institut an der Veterinärmedizinischen Universität Wien Reconstituting retroviral vector (recon vector) for targeted gene expression

Also Published As

Publication number Publication date
AU5103996A (en) 1996-10-02
JPH11503305A (ja) 1999-03-26
WO1996028563A1 (en) 1996-09-19
US7022319B1 (en) 2006-04-04
PT817858E (pt) 2003-09-30
DE69627644D1 (de) 2003-05-28
EP0817858B1 (en) 2003-04-23
EP0817858A1 (en) 1998-01-14
DE69627644T2 (de) 2004-02-19
ES2198479T3 (es) 2004-02-01
JP3908274B2 (ja) 2007-04-25
ATE238427T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
DK0817858T3 (da) Vektorer, som indeholder terapeutiske gener for antimikrobielle peptider, til anvendelse ved genterapi
EP1017797A4 (en) NON-ORIGINATING PRIMATE LENTIVIRUS VECTORS AND PACKAGING SYSTEMS
EP1005376A4 (en) METHODS AND COMPOSITIONS FOR USE IN GENE THERAPY IN THE TREATMENT OF HEMOPHILIA
WO1997032991A3 (en) Gene therapy for the treatment of solid tumors using recombinant adeno-associated virus vectors
HUP9902310A2 (hu) Komplementer adenovírus-vektorrendszerek és sejtvonalak
HUP0204199A2 (hu) Transzport vektorok
ATE386131T1 (de) Aav-vermittelte überbringung von dna in zellen des nervensystems
ATE259828T1 (de) Prosaposin und cytokinabhängige peptide als therapeutisch wirksame mittel
BR9407956A (pt) Composiçao farmacêutica vetor de express o de adenovirus recombinante e kit par reduzir a proliferaçao de células tumorais
ATE288496T1 (de) Gentherapie mit hilfe von schaf-adenoviralen vektoren
WO2002097038A3 (en) Chemokine beta-1 fusion proteins
NZ320889A (en) A p35 protein which binds to and inhibits chemokines
CA2234263A1 (fr) Composition pharmaceutique contre les tumeurs et infections a papillomavirus
WO1997022695A3 (fr) Sequences nucleotidiques, proteines, medicaments et agents diagnostiques utiles dans le traitement du cancer
PT835137E (pt) Celulas encapsuladas produtoras de particulas virais
HK1041288B (zh) Akt-3核酸、多肽及其用途
IL117194A0 (en) Amplifying sequences vectors comprising them and their uses in compositions for the expression of nucleotide sequences and pharmaceutical compositions containing them
HUP9802587A2 (hu) Glükózzal indukálható rekombináns virális vektor, ezt tartalmazó gyógyszerkészítmény és ezzel transzformált sejtek
NZ324157A (en) Conditionally replicating viral vectors and their use in treating HIV
NZ793468A (en) Gene therapy with dysferlin dual vectors
IT1262545B (it) Sistema di espressione per linee cellulari eucariotiche
AU1275095A (en) Antiviral composition of viral protein trans-dominant variants
WO2023235888A3 (en) Cpg-reduced polynucleotides, viral vectors and their use in therapy
DK0670904T3 (da) Vektor til ekspression af terapeutisk relevante gener
CA2086577A1 (en) Potential target for immunotherapy to prevent replication of hiv (aids virus) in humans: cdna and protein for a putative regulator of hiv gag polyprotein expression reconstructed from the antisense strand of human p53 gene